Article Information
History
- October 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- R.S.G. Sablerolles, MD1,2,
- W.J.R. Rietdijk, PhD2,
- A. Goorhuis, MD PhD3,4,
- D.F. Postma, MD PhD5,
- Prof. L.G. Visser6,
- D. Geers, Msc7,
- K.S. Schmitz, MSc7,
- H.M. Garcia Garrido, MD3,
- Prof. M.P.G. Koopmans7,
- V.A.S.H. Dalm, MD PhD8,
- N.A. Kootstra, PhD9,
- Prof. A.L.W. Huckriede10,
- M. Lafeber, MD PhD1,
- Prof. D. van Baarle10,11,
- C.H. GeurtsvanKessel, MD PhD7,†,
- R.D. de Vries, PhD7,†,
- Prof. P.H.M. van der Kuy2,†,* and
- on behalf of the SWITCH research group
- 1Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
- 2Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands
- 3Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands
- 4Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands
- 5Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, the Netherlands
- 6Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands
- 7Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
- 8Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands
- 9Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands
- 10Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 11Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
- ↵*Corresponding author: P.H.M. van der Kuy, Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, 3015 GD, the Netherlands. E-mail: h.vanderkuy{at}erasmusmc.nl.
↵† contributed equally
Posted October 22, 2021.
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
